Key statistics
On Tuesday, United Therapeutics Corp (UTH:FRA) closed at 397.30, -9.87% below its 52-week high of 440.80, set on Dec 22, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 397.30 |
|---|---|
| High | 397.30 |
| Low | 397.30 |
| Bid | 397.30 |
| Offer | 397.90 |
| Previous close | 409.60 |
| Average volume | 25.80 |
|---|---|
| Shares outstanding | 43.06m |
| Free float | 42.26m |
| P/E (TTM) | 17.91 |
| Market cap | 20.37bn USD |
| EPS (TTM) | 26.41 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 07:04 GMT.
More ▼
Press releases
- United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure
- United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors
- ReAlta Life Sciences Announces Appointment of Jonathan Rigby to Board of Directors
- United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
